SGHT guidance is weak and hopefully a reflection of them losing share.
"Sight Sciences projects revenue for full year 2024 to range from approximately $81.0 million to $85.0 million, representing a range of 0% to 5% growth compared to 2023. The Company expects double-digit revenue growth in the second half of 2024 versus the comparable periods in the prior year as it regains commercial momentum and expands utilization and its customer base."
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
SGHT guidance is weak and hopefully a reflection of them losing...
-
- There are more pages in this discussion • 776 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.0¢ |
Change
-0.015(7.69%) |
Mkt cap ! $41.23M |
Open | High | Low | Value | Volume |
19.0¢ | 19.0¢ | 18.0¢ | $64.64K | 347.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 212736 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 52303 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 212736 | 0.180 |
5 | 192714 | 0.175 |
2 | 2900 | 0.170 |
1 | 30000 | 0.165 |
3 | 110100 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 52303 | 2 |
0.190 | 37004 | 2 |
0.195 | 29999 | 1 |
0.200 | 43423 | 1 |
0.205 | 44282 | 2 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |